Worth reading
58In focus
0–100. This measures how worthwhile something is to read, not how good or bad the company is.Direction
Mixed performance
Direction inferred from the company’s description.Scale
692
¥ million (year-on-year increase in revenue)Wording
Conditional
How definitive the wording is.Contents of this document
Financial results presentationFirst quarter of the fiscal year ending March 202710 items taken from the company’s own explanation
Financial Results Figures (The key points of this material are explained below)
Net Sales¥7,298 million+10.5%
Operating profit¥-347 million
Ordinary income¥-519 million
Net income¥-557 million
Selling, general and administrative expenses¥396 million administrative personnel expenses
Results for the three months of the current quarterRevenue: ¥7,298 million; EBITDA: ¥115 million; operating loss: ¥347 million; ordinary loss: ¥519 million; quarterly net loss: ¥557 million
Full-year earnings forecast
Net Sales
¥28,872 million
EBITDA
¥2,402 million
Operating profit
¥420 million
Ordinary income
¥-854 million
Net income for the current fiscal year
¥-1,060 million
Progress against full-year forecast 通期の予想に対して、いまどこまで進んだかの割合です。Achievement rates against the first-quarter budget were 99.4% for revenue and 36.3% for EBITDA. No achievement rates were provided for operating profit, ordinary profit or quarterly net profit.
What the company explained in this material
Self-assessment against the planThe company's self-assessment against its own plan.
Revenue and profit came in below planBreakdown of Factors Affecting the ChangeReasons cited by the Company for the change in the figures.
- Changes in revenue at facilities opened by the fiscal year ending March 2025¥47 million
- Changes in personnel expenses included in cost of sales at facilities opened by the fiscal year ending March 2025¥-272 million
- Changes in revenue at facilities opened in the fiscal year ending March 2026¥965 million
- Changes in personnel expenses included in cost of sales at facilities opened in the fiscal year ending March 2026¥-720 million
- Changes in land and rental expenses included in cost of sales¥-17 million
- Changes in personnel expenses included in SG&A¥34 million
- Other¥173 million
Assumptions Underlying the Business OutlookThe assumptions used by the company in preparing its forecast.
Profit is expected to improve quarter by quarter as the number of residents increases and staffing levels are reviewed in response to the medical fee schedule revision.New initiatives
- In-house provision of facility cleaning and meal services
- Review of entrance fees, usage fees and other charges
- Assignment of dedicated sales personnel to each area
- Redesign of staffing standards for PD House facilities
- Reduction of administrative expenses and optimization of administrative staffing
- Application to change the market segment to the Standard Market
Key KPIsA metric the company considers important as a management benchmark.
- Number of PD House facilities56 FacilityYear on year against the same period last year+10 facilities, +21.7%
- Occupancy rate across all PD House facilities79 ％Year on year against the same period last yearPrior-year comparable figure not provided
- Number of residents across all PD House facilities2,417 peopleYear on year against the same period last yearPrior-year comparable figure not provided
- Number of vacant beds653 bedsYear on year against the same period last yearPrior-year comparable figure not provided
- Number of new hires145 peopleYear on year against the same period last year297 people in the prior-year period
- Employee turnover rate12 ％Year on year against the same period last yearPrior-year comparable figure not provided
- Number of holders of the PD License Level 1166 People, certification rate 5%Year on year against the same period last yearNot conducted in the prior-year period
- Number of holders of the PD License Level 2335 People, certification rate 11%Year on year against the same period last year377 people in the prior-year period, certification rate 14%
- Number of holders of the PD License Level 32,744 People, certification rate 88%Year on year against the same period last year2,382 people in the prior-year period, certification rate 88%
- Number of affiliated neurologists125 peopleYear on year against the same period last yearPrior-year comparable figure not provided
Unit price and quantity metricsThese figures show sales broken down by price and volume.
Monthly revenue per resident is presented by medical insurance revenue, long-term care insurance revenue and self-pay revenue before and after the medical fee schedule revision. Medical insurance revenue was approximately ¥580,000 before the revision and approximately ¥350,000–¥400,000 after it; long-term care insurance revenue was approximately ¥250,000 and self-pay revenue was approximately ¥150,000–¥200,000.Financial targets
The equity ratio was 14.2% at the end of June 2026, compared with 15.2% at the end of March 2026. Target: Not disclosedMarket Size / Share
Approximately 205,000 patients with Parkinson's disease and related conditions, approximately 81,000 hospital inpatients and residents of care facilities, PD House capacity of 3,070, and a market share of 3.8%Number of stores and locations
End of period56 PD House facilities (at the end of June 2026)
Number of store openings and closures during the period0 facilities scheduled to open during the current fiscal year. No new openings were reported for the first quarter.
Number of employees
Number of Employees3,636 people (at the end of June 2026; chart includes temporary employees)
Changes during the period and hiring plan145 hires in the first quarter, 250 hires planned for the current fiscal year, and 3,150 employees planned at fiscal year-end
| Item | Details |
|---|---|
| Document type | Financial results presentation |
| Fiscal Period Covered | First quarter of the fiscal year ending March 2027 |
| Net Sales | ¥7,298 million (YoY +10.5%) |
| Operating profit | ¥-347 million |
| Ordinary income | ¥-519 million |
| Net income | ¥-557 million |
| Selling, general and administrative expenses | ¥396 million (administrative personnel expenses) |
| Results for the three months of the current quarter | Revenue: ¥7,298 million; EBITDA: ¥115 million; operating loss: ¥347 million; ordinary loss: ¥519 million; quarterly net loss: ¥557 million |
| Full-year earnings forecast | Net Sales ¥28,872 million / EBITDA ¥2,402 million / Operating profit ¥420 million / Ordinary income ¥-854 million / Net income for the current fiscal year ¥-1,060 million |
| Progress against full-year forecast | Achievement rates against the first-quarter budget were 99.4% for revenue and 36.3% for EBITDA. No achievement rates were provided for operating profit, ordinary profit or quarterly net profit. |
| Self-assessment against the plan | Revenue and profit came in below plan |
| Breakdown of Factors Affecting the Change | Factors Changes in revenue at facilities opened by the fiscal year ending March 2025 / Amount ¥47 million, Factors Changes in personnel expenses included in cost of sales at facilities opened by the fiscal year ending March 2025 / Amount ¥-272 million, Factors Changes in revenue at facilities opened in the fiscal year ending March 2026 / Amount ¥965 million, Factors Changes in personnel expenses included in cost of sales at facilities opened in the fiscal year ending March 2026 / Amount ¥-720 million, Factors Changes in land and rental expenses included in cost of sales / Amount ¥-17 million, Factors Changes in personnel expenses included in SG&A / Amount ¥34 million, Factors Other / Amount ¥173 million |
| Key KPIs | Indicator Number of PD House facilities / Value 56 Facility / Year on year against the same period last year +10 facilities, +21.7%, Indicator Occupancy rate across all PD House facilities / Value 79 ％ / Year on year against the same period last year Prior-year comparable figure not provided, Indicator Number of residents across all PD House facilities / Value 2,417 people / Year on year against the same period last year Prior-year comparable figure not provided, Indicator Number of vacant beds / Value 653 beds / Year on year against the same period last year Prior-year comparable figure not provided, Indicator Number of new hires / Value 145 people / Year on year against the same period last year 297 people in the prior-year period, Indicator Employee turnover rate / Value 12 ％ / Year on year against the same period last year Prior-year comparable figure not provided, Indicator Number of holders of the PD License Level 1 / Value 166 People, certification rate 5% / Year on year against the same period last year Not conducted in the prior-year period, Indicator Number of holders of the PD License Level 2 / Value 335 People, certification rate 11% / Year on year against the same period last year 377 people in the prior-year period, certification rate 14%, Indicator Number of holders of the PD License Level 3 / Value 2,744 People, certification rate 88% / Year on year against the same period last year 2,382 people in the prior-year period, certification rate 88%, Indicator Number of affiliated neurologists / Value 125 people / Year on year against the same period last year Prior-year comparable figure not provided |
| Unit price and quantity metrics | Monthly revenue per resident is presented by medical insurance revenue, long-term care insurance revenue and self-pay revenue before and after the medical fee schedule revision. Medical insurance revenue was approximately ¥580,000 before the revision and approximately ¥350,000–¥400,000 after it; long-term care insurance revenue was approximately ¥250,000 and self-pay revenue was approximately ¥150,000–¥200,000. |
| Number of stores and locations | End of period 56 PD House facilities (at the end of June 2026) / Number of store openings and closures during the period 0 facilities scheduled to open during the current fiscal year. No new openings were reported for the first quarter. |
| Number of employees | Number of Employees 3,636 people (at the end of June 2026; chart includes temporary employees) / Changes during the period and hiring plan 145 hires in the first quarter, 250 hires planned for the current fiscal year, and 3,150 employees planned at fiscal year-end |
| Assumptions Underlying the Business Outlook | Profit is expected to improve quarter by quarter as the number of residents increases and staffing levels are reviewed in response to the medical fee schedule revision. |
| Financial targets | The equity ratio was 14.2% at the end of June 2026, compared with 15.2% at the end of March 2026. Target: Not disclosed |
| Market Size / Share | Approximately 205,000 patients with Parkinson's disease and related conditions, approximately 81,000 hospital inpatients and residents of care facilities, PD House capacity of 3,070, and a market share of 3.8% |
| New initiatives | In-house provision of facility cleaning and meal services, Review of entrance fees, usage fees and other charges, Assignment of dedicated sales personnel to each area, Redesign of staffing standards for PD House facilities, Reduction of administrative expenses and optimization of administrative staffing, Application to change the market segment to the Standard Market |
Items this document does not state (11)
Gross Profit MarginOperating profit marginSegment resultsRisk amount incorporated into the outlookMedium-term management plan targetsAnnual DividendPayout ratioAcquisition of treasury sharesCapital expendituresOrders received and order backlogKey points of the Q&A
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The company explained that although medical insurance revenue declined following the medical fee schedule revision, results improved year on year due to an increase in the number of residents, higher occupancy at facilities opened in the previous fiscal year and cost reductions. The company attributed the shortfall against budget to delays in attracting residents and said that paying a treatment improvement subsidy as bonuses affected the budget-to-actual variances for EBITDA and operating profit.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.